HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:HCXY • US4270968476

25.3 USD
+0.01 (+0.04%)
Last: Feb 10, 2026, 03:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, HCXY scores 4 out of 10 in our fundamental rating. HCXY was compared to 238 industry peers in the Capital Markets industry. While HCXY is still in line with the averages on profitability rating, there are concerns on its financial health. HCXY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year HCXY was profitable.
  • HCXY had a negative operating cash flow in the past year.
  • HCXY had positive earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: HCXY reported negative operating cash flow in multiple years.
HCXY Yearly Net Income VS EBIT VS OCF VS FCFHCXY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • The Return On Assets of HCXY (6.97%) is better than 78.57% of its industry peers.
  • With a decent Return On Equity value of 14.04%, HCXY is doing good in the industry, outperforming 73.95% of the companies in the same industry.
  • The Return On Invested Capital of HCXY (6.11%) is better than 73.95% of its industry peers.
  • HCXY had an Average Return On Invested Capital over the past 3 years of 6.33%. This is in line with the industry average of 7.27%.
Industry RankSector Rank
ROA 6.97%
ROE 14.04%
ROIC 6.11%
ROA(3y)6.62%
ROA(5y)7.02%
ROE(3y)12.91%
ROE(5y)13.88%
ROIC(3y)6.33%
ROIC(5y)5.69%
HCXY Yearly ROA, ROE, ROICHCXY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 59.47%, HCXY belongs to the best of the industry, outperforming 92.44% of the companies in the same industry.
  • HCXY's Profit Margin has declined in the last couple of years.
  • HCXY's Operating Margin of 64.99% is amongst the best of the industry. HCXY outperforms 97.90% of its industry peers.
  • In the last couple of years the Operating Margin of HCXY has grown nicely.
  • HCXY's Gross Margin of 81.23% is amongst the best of the industry. HCXY outperforms 85.29% of its industry peers.
  • HCXY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 64.99%
PM (TTM) 59.47%
GM 81.23%
OM growth 3Y7.36%
OM growth 5Y4.3%
PM growth 3Y-4.94%
PM growth 5Y-4%
GM growth 3Y2.12%
GM growth 5Y1.42%
HCXY Yearly Profit, Operating, Gross MarginsHCXY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, HCXY has more shares outstanding
  • Compared to 5 years ago, HCXY has more shares outstanding
  • Compared to 1 year ago, HCXY has a worse debt to assets ratio.
HCXY Yearly Shares OutstandingHCXY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
HCXY Yearly Total Debt VS Total AssetsHCXY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • HCXY has an Altman-Z score of 1.64. This is a bad value and indicates that HCXY is not financially healthy and even has some risk of bankruptcy.
  • HCXY has a Altman-Z score of 1.64. This is in the better half of the industry: HCXY outperforms 65.97% of its industry peers.
  • HCXY has a Debt/Equity ratio of 0.98. This is a neutral value indicating HCXY is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.98, HCXY perfoms like the industry average, outperforming 48.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 1.64
ROIC/WACCN/A
WACCN/A
HCXY Yearly LT Debt VS Equity VS FCFHCXY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • HCXY has a Current Ratio of 0.95. This is a bad value and indicates that HCXY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HCXY has a Current ratio (0.95) which is comparable to the rest of the industry.
  • HCXY has a Quick Ratio of 0.95. This is a bad value and indicates that HCXY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.95, HCXY perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
HCXY Yearly Current Assets VS Current LiabilitesHCXY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • HCXY shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.21%.
  • HCXY shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.35% yearly.
  • Looking at the last year, HCXY shows a very negative growth in Revenue. The Revenue has decreased by -16.09% in the last year.
  • Measured over the past years, HCXY shows a quite strong growth in Revenue. The Revenue has been growing by 13.00% on average per year.
EPS 1Y (TTM)-7.21%
EPS 3Y16.54%
EPS 5Y7.35%
EPS Q2Q%-3.92%
Revenue 1Y (TTM)-16.09%
Revenue growth 3Y20.66%
Revenue growth 5Y13%
Sales Q2Q%10.26%

3.2 Future

  • Based on estimates for the next years, HCXY will show a small growth in Earnings Per Share. The EPS will grow by 1.33% on average per year.
  • HCXY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.69% yearly.
EPS Next Y-2.17%
EPS Next 2Y1.19%
EPS Next 3Y1.33%
EPS Next 5YN/A
Revenue Next Year6.74%
Revenue Next 2Y8.17%
Revenue Next 3Y8.69%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HCXY Yearly Revenue VS EstimatesHCXY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
HCXY Yearly EPS VS EstimatesHCXY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • HCXY is valuated correctly with a Price/Earnings ratio of 13.11.
  • Compared to the rest of the industry, the Price/Earnings ratio of HCXY is on the same level as its industry peers.
  • HCXY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.06.
  • HCXY is valuated correctly with a Price/Forward Earnings ratio of 12.29.
  • 61.34% of the companies in the same industry are more expensive than HCXY, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 27.86. HCXY is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.11
Fwd PE 12.29
HCXY Price Earnings VS Forward Price EarningsHCXY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • HCXY's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HCXY is cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.98
HCXY Per share dataHCXY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The decent profitability rating of HCXY may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.78
EPS Next 2Y1.19%
EPS Next 3Y1.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • HCXY has a Yearly Dividend Yield of 9.80%, which is a nice return.
  • HCXY's Dividend Yield is a higher than the industry average which is at 6.13.
  • Compared to an average S&P500 Dividend Yield of 1.80, HCXY pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.8%

5.2 History

  • The dividend of HCXY is nicely growing with an annual growth rate of 7.41%!
  • HCXY has been paying a dividend for over 5 years, so it has already some track record.
  • HCXY has decreased its dividend in the last 3 years.
Dividend Growth(5Y)7.41%
Div Incr Years0
Div Non Decr Years2
HCXY Yearly Dividends per shareHCXY Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 104.41% of the earnings are spent on dividend by HCXY. This is not a sustainable payout ratio.
  • HCXY's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP104.41%
EPS Next 2Y1.19%
EPS Next 3Y1.33%
HCXY Yearly Income VS Free CF VS DividendHCXY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M
HCXY Dividend Payout.HCXY Dividend Payout, showing the Payout Ratio.HCXY Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33

NYSE:HCXY (2/10/2026, 3:59:00 PM)

25.3

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-30
Earnings (Next)02-12
Inst Owners28.19%
Inst Owner ChangeN/A
Ins Owners1.73%
Ins Owner ChangeN/A
Market Cap4.60B
Revenue(TTM)516.85M
Net Income(TTM)307.37M
Analysts84
Price Target29.4 (16.21%)
Short Float %0%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield 9.8%
Yearly Dividend1.85
Dividend Growth(5Y)7.41%
DP104.41%
Div Incr Years0
Div Non Decr Years2
Ex-Date01-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.18%
Min EPS beat(2)0.34%
Max EPS beat(2)4.02%
EPS beat(4)2
Avg EPS beat(4)-1.44%
Min EPS beat(4)-5.11%
Max EPS beat(4)4.02%
EPS beat(8)3
Avg EPS beat(8)-0.29%
EPS beat(12)7
Avg EPS beat(12)1.81%
EPS beat(16)9
Avg EPS beat(16)1.52%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)0.25%
Max Revenue beat(2)3.19%
Revenue beat(4)2
Avg Revenue beat(4)-1.68%
Min Revenue beat(4)-6.05%
Max Revenue beat(4)3.19%
Revenue beat(8)4
Avg Revenue beat(8)5.13%
Revenue beat(12)8
Avg Revenue beat(12)4.68%
Revenue beat(16)9
Avg Revenue beat(16)3.06%
PT rev (1m)0.81%
PT rev (3m)-3.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.13%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)0.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.69%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 13.11
Fwd PE 12.29
P/S 8.9
P/FCF N/A
P/OCF N/A
P/B 2.1
P/tB 2.1
EV/EBITDA 19.98
EPS(TTM)1.93
EY7.63%
EPS(NY)2.06
Fwd EY8.13%
FCF(TTM)-2.2
FCFYN/A
OCF(TTM)-2.2
OCFYN/A
SpS2.84
BVpS12.05
TBVpS12.05
PEG (NY)N/A
PEG (5Y)1.78
Graham Number22.88
Profitability
Industry RankSector Rank
ROA 6.97%
ROE 14.04%
ROCE 7.74%
ROIC 6.11%
ROICexc 6.15%
ROICexgc 6.16%
OM 64.99%
PM (TTM) 59.47%
GM 81.23%
FCFM N/A
ROA(3y)6.62%
ROA(5y)7.02%
ROE(3y)12.91%
ROE(5y)13.88%
ROIC(3y)6.33%
ROIC(5y)5.69%
ROICexc(3y)6.48%
ROICexc(5y)5.92%
ROICexgc(3y)6.5%
ROICexgc(5y)5.93%
ROCE(3y)8.02%
ROCE(5y)7.21%
ROICexgc growth 3Y12.85%
ROICexgc growth 5Y8.03%
ROICexc growth 3Y12.87%
ROICexc growth 5Y8%
OM growth 3Y7.36%
OM growth 5Y4.3%
PM growth 3Y-4.94%
PM growth 5Y-4%
GM growth 3Y2.12%
GM growth 5Y1.42%
F-Score1
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 6.4
Cap/Depr 17.58%
Cap/Sales 0.01%
Interest Coverage 4.18
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 1.64
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)222.71%
Cap/Depr(5y)145.29%
Cap/Sales(3y)0.12%
Cap/Sales(5y)0.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.21%
EPS 3Y16.54%
EPS 5Y7.35%
EPS Q2Q%-3.92%
EPS Next Y-2.17%
EPS Next 2Y1.19%
EPS Next 3Y1.33%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.09%
Revenue growth 3Y20.66%
Revenue growth 5Y13%
Sales Q2Q%10.26%
Revenue Next Year6.74%
Revenue Next 2Y8.17%
Revenue Next 3Y8.69%
Revenue Next 5YN/A
EBIT growth 1Y-18.05%
EBIT growth 3Y29.54%
EBIT growth 5Y17.86%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-212.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-213.28%
OCF growth 3YN/A
OCF growth 5YN/A

HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 / HCXY FAQ

Can you provide the ChartMill fundamental rating for HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33?

ChartMill assigns a fundamental rating of 4 / 10 to HCXY.


What is the valuation status of HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) stock?

ChartMill assigns a valuation rating of 4 / 10 to HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY). This can be considered as Fairly Valued.


Can you provide the profitability details for HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33?

HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) has a profitability rating of 6 / 10.


Can you provide the financial health for HCXY stock?

The financial health rating of HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) is 1 / 10.


What is the expected EPS growth for HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) stock?

The Earnings per Share (EPS) of HERCULES CAPITAL INC - HTGC 6 1/4 10/30/33 (HCXY) is expected to decline by -2.17% in the next year.